Albuterol Sulfate
Product Images NDC 53002-1551

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 53002-1551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Albuterol Sulfate Hfa N021457 1)

Chemical structure of Albuterol Sulfate, showing the molecular arrangement of its atoms including the aromatic ring, hydroxyl groups, amine, and sulfate ions.*

FDA Label Image

Figures G And H (Albuterol Sulfate Hfa N021457 10)

An instructional diagram showing proper use of an inhaler labeled Albuterol Sulfate HFA by RPK Pharmaceuticals. Figure G demonstrates a blocked inhaler with little to no medicine output, whereas Figure H shows an unblocked inhaler releasing medicine spray correctly.*

FDA Label Image

Figure I (Albuterol Sulfate Hfa N021457 11)

An instructional illustration showing a hand holding a mouthpiece under a faucet with running water. The accompanying text instructs to wash the mouthpiece under warm running water. This is Figure I in an instructions sequence.*

FDA Label Image

Figure J (Albuterol Sulfate Hfa N021457 12)

An instructional illustration showing a hand holding an Albuterol Sulfate HFA inhaler under running water from a faucet, demonstrating cleaning of the inhaler mouthpiece.*

FDA Label Image

Figure K (Albuterol Sulfate Hfa N021457 13)

An instructional illustration showing three views of an inhaler mouthpiece and a note advising to allow the mouthpiece to dry overnight. The image emphasizes proper maintenance and drying of the mouthpiece after use.*

FDA Label Image

Day 1 Image (Albuterol Sulfate Hfa N021457 2)

A line graph depicting the percentage change in FEV1 over time (hours) following administration of Albuterol Sulfate HFA Inhalation Aerosol, Matched Placebo HFA Inhalation Aerosol, and Marketed HFA-134a Albuterol Inhaler. The graph includes three lines representing each treatment group with a sample size of around 56-58 participants each.*

FDA Label Image

Day 43 Image (Albuterol Sulfate Hfa N021457 3)

A line graph depicting the percent change in FEV1 over 6 hours for three inhalation aerosols: Albuterol Sulfate HFA (N=52), Matched Placebo HFA (N=49), and Marketed HFA-134a Albuterol Inhaler (N=49). The graph shows the Albuterol Sulfate HFA reaching the highest peak change shortly after administration compared to the other products, with all lines converging near the end of the period.*

FDA Label Image

Teva Logo (Albuterol Sulfate Hfa N021457 4)

FDA Label Image

Figures A And B (Albuterol Sulfate Hfa N021457 5)

An instructional diagram showing parts of an Albuterol Sulfate HFA inhaler. Figure A labels the metal canister, cap, mouthpiece, and plastic actuator. Figure B highlights the dose counter feature on the inhaler device.*

FDA Label Image

Figure C (Albuterol Sulfate Hfa N021457 6)

An instructional illustration depicting a person holding and using an Albuterol Sulfate HFA inhaler by placing the mouthpiece in the mouth and pressing down on the canister to release the medication.*

FDA Label Image

Figure D (Albuterol Sulfate Hfa N021457 7)

Illustration showing the dose counter on an Albuterol Sulfate HFA inhaler, indicating the number 200, which represents the remaining doses available for use. The image highlights the location of the dose counter on the inhaler device.*

FDA Label Image

Figure E (Albuterol Sulfate Hfa N021457 8)

An instructional illustration showing how to hold an Albuterol Sulfate HFA inhaler in the mouthpiece-down position. The image depicts a hand holding the inhaler with the cap removed, labeled components include the mouthpiece and the cap. The inhaler label advises to shake well before use.*

FDA Label Image

Figure F (Albuterol Sulfate Hfa N021457 9)

An instructional illustration showing a person using an inhaler. The image includes the text 'Push down and breathe in,' demonstrating proper inhaler use, likely associated with Albuterol Sulfate HFA by RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021551)

Albuterol Sulfate HFA Inhaler label from RPK Pharmaceuticals, Inc., showing dosage instructions for 2 puffs every 4-6 hours as needed. The label includes details on the inhaler's contents and usage with product NDC 53002-1551. The text is organized with patient directions, warnings, and labeler information, featuring the proprietary name prominently.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.